Terminal leukaemia patients who were not responding to treatment now have hope for a cure, thanks to a new experimental pill called revumenib.
This drug has completely eliminated cancer in a third of the participants in a long-awaited clinical trial in the United States.
Although not all patients showed complete remission, scientists remain hopeful as the results indicate that the pill might pave the way to a cure for leukaemia in the future.
New leukimia treatment
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.4¢ |
Change
0.005(6.33%) |
Mkt cap ! $607.5M | |||
| Open | High | Low | Value | Volume |
| 8.0¢ | 8.4¢ | 7.9¢ | $869.4K | 10.58M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 198734 | 8.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.4¢ | 346492 | 10 |
View Market Depth
| Last trade - 14.35pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
8.3¢ |
Change
0.005 ( 4.93 %) |
||||
| Open | High | Low | Volume | ||
| 8.0¢ | 8.4¢ | 8.0¢ | 3956227 | ||
| Last updated 14.48pm 29/04/2024 ? | |||||
| IMU (ASX) Chart |